Description
Semax is a synthetic heptapeptide developed for in-vitro and preclinical research applications. It is structurally derived from adrenocorticotropic hormone (ACTH) fragments and is widely used in research exploring peptide signaling, neurochemical pathways, and receptor interaction models.
Within controlled laboratory environments, Semax is studied for its stability, molecular behavior, and interaction with cellular systems involved in signaling and communication processes. The peptide is manufactured to high purity specifications to support consistency, reproducibility, and reliability across experimental protocols.
Semax is supplied strictly for scientific research purposes and is not approved for clinical, diagnostic, or therapeutic use.





Reviews
There are no reviews yet.